期刊文献+

糖尿病患者冠状动脉内支架术后的远期疗效 被引量:5

Long-term outcomes after elective coronary stenting in diabetic patients
原文传递
导出
摘要 目的 探讨糖尿病患者选择性冠状动脉 (冠脉 )内支架术的远期疗效。方法  80 8例冠心病患者行选择性冠脉内支架术 ,其中糖尿病组 174例 ,非糖尿病组 6 34例。随访两组患者远期结果。结果 两组支架术成功率 (96 0 %和 96 1% )相似。平均随访 (19± 7 8)个月 (6~ 4 2个月 ) ,临床随访率为 95 3%。随访期内 ,与非糖尿病组相比 ,糖尿病组心功能改善者 (5 2 2 %比 6 1 0 % )较少 ,再住院率 (4 2 7%比 32 5 % )增加 ;且心脏事件 (30 6 %比 2 2 2 % )、再狭窄 (19 1%比 12 5 % )及总死亡(10 2 %比 4 6 % )均显著增加。多因素分析显示 ,糖尿病为死亡 (OR =2 2 0 ,95 %CI 1 12~ 4 33,P =0 0 2 2 )和再狭窄 (OR =1 6 6 ,95 %CI 1 0 4~ 2 6 7,P =0 0 35 )的独立预测因素。结论 糖尿病患者选择性冠脉内支架术远期结果可以接受 ,但糖尿病仍是远期不良预后的独立预测因素。 Objective To observe the long-term outcomes following coronary stenting in diabetic patients with coronary artery disease. Methods This cohort study comprised 808 consecutive patients with coronary artery disease who underwent elective coronary stenting,including 174 diabetic patients and 634 non-diabetic patients. The long-term follow-up outcomes were compared. Results Procedural success rate was similar (96.0% vs 96.1%). Follow-up rate was 95.3%. Mean follow-up duration was (19±7.8) months(ranged from 6 to 42 months). Compared with non-diabetic patients,diabetic patients had less improvement of cardiac function (52.2% vs 61.0%),more re-admission (42.7% vs 32.5%),and higher occurrence rates of major adverse cardiac events (30.6% vs 22.2%),angiographic restenosis rate (19.1% vs 12.5%) and mortality (10.2% vs 4.6%). Logistic regression analysis indicated that diabetes mellitus was an independent predicator of death (odd ratio 2.20,95%CI 1.12~4.33,P=0.022) and restenosis (odd ratio 1.66, 95%CI 1.04~2.67,P=0.035). Conclusion Diabetic patients undergoing elective coronary stenting have acceptable long-term outcomes,but diabetes mellitus is still independently associated with worse late prognosis.
出处 《中华内科杂志》 CAS CSCD 北大核心 2004年第6期433-435,共3页 Chinese Journal of Internal Medicine
关键词 糖尿病 冠状动脉内支架术 冠心病 术后并发症 预后 Coronary artery disease Stent Diabetes mellitus Prognosis
  • 相关文献

参考文献9

  • 1The Bypass Angioplasty Revascularization Investigation(BARI) Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing of CABG and PTCA in patients with multivessel disease. Circulation, 1997, 96:1761-1769.
  • 2Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol, 1998,32:1866-1873.
  • 3Marso SP, Lincoff AM, Ellis SG, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation,1999 ,100
  • 4Laskey WK, Selzer F, Vlachos HA, et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am
  • 5Van Belle E, Perie M, Braune D, et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol, 2002,40:410-417.
  • 6Shen WF, Zhang RY, Shen Y, et al. Optimal tining for coronary stenting in unstable angina. Clin Med J, 2001,114:59-61.
  • 7Van Belle E, Abolmaali K, Bauters C, et al. Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. J Am Coll Cardiol, 1999, 34:476-485.
  • 8Mathew V, Holmes DR. Outcomes in diabetics undergoing revascularization: the long and the short of it. J Am Coll Cardiol, 2002, 40:424-427.
  • 9Quinn MJ, Moliterno DJ. Diabetes and percutaneous coronary intervention: the sweet smell of success? Am Heart J, 2003,145:203-205.

共引文献1

同被引文献30

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部